US 12012384
Dextrorphan prodrugs and processes for making and using them
granted A61KA61K47/542A61P
Quick answer
US patent 12012384 (Dextrorphan prodrugs and processes for making and using them) held by Zevra Therapeutics, Inc. expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Zevra Therapeutics, Inc.
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K47/542, A61P, A61P11/14, A61P25/36